Australian Clinical Labs (ASX: ACL) — Company Overview, News & Financial Data
Australian Clinical Labs provides a comprehensive range of pathology services across Australia, ensuring high-quality and affordable solutions.
Australian Clinical Labs
Australian Clinical Labs is a private provider of pathology and medical laboratory services based in Australia. The organization operates a nationwide network of laboratory facilities and patient collection centers, serving general practitioners, medical specialists, private and public hospitals, clinical trial sponsors, and commercial corporate clients. Its service portfolio includes routine diagnostic pathology across hematology, biochemistry, and microbiology, alongside specialized offerings in genetic testing, non-invasive prenatal screening, molecular cancer diagnostics, cardiac testing, and occupational health screening. The company also integrates digital health technology tools to deliver electronic pathology requesting and results management to medical practices across Australia.
Snapshot
Operations
Products and/or services of Australian Clinical Labs
- Routine Pathology Testing: Comprehensive diagnostic pathology services encompassing hematology, clinical chemistry, microbiology, and histopathology for general practitioners, medical specialists, and public and private hospital clients across an extensive national network of collection centers and laboratories.
- Specialised Diagnostic Testing: Advanced diagnostic pathology solutions including antenatal screening, cardiac biomarker evaluation, cervical screening, respiratory pathogen panels, sexually transmitted infection analysis, and comprehensive allergy diagnostic testing for medical practitioners and patient management.
- Genetic Testing Services: Advanced genomic diagnostic offerings covering non-invasive prenatal testing, genetic carrier screening for inherited disorders, pharmacogenetic analysis for targeted medication selection, and specialized molecular cancer diagnostic testing for oncology patients.
- Commercial Pathology Services: Tailored occupational health testing solutions comprising workplace drug and alcohol screening, pre-employment health evaluations, employee immunity assessments, biological monitoring, and environmental water testing for industrial and corporate organizations.
- Clinical Trials Services: Central laboratory and analytical trial support services providing customized diagnostic protocols, specialized specimen handling, trial logistics, and regulatory-compliant testing services for pharmaceutical companies, biotechnology firms, and research institutions.
- Digital Pathology Integration: Health technology solutions facilitating electronic pathology requesting, automated result distribution, digital courier ordering systems, mobile SMS patient test notifications, and direct electronic medical record software integration for healthcare providers.
Australian Clinical Labs executive team
- Gregory John HoranGroup CEO, MD & Executive Director
- Anthony FriedliChief Operating Officer
- Sean JacksonChief Information Officer
- Joe GeranNational Marketing Director
- Associate Prof. Tony LandgrenNational Medical Director & Chief Pathologist
- Chris BrownlowChief Executive Officer of New South Wales & Australian Capital Territory
- Shae SeymourChief Risk Officer & CEO of WA/SA/NT
- Eleanor PadmanCompany Secretary
- Darren McKeeChief Executive Officer of Victoria
Latest news about Australian Clinical Labs
Optiscan Imaging completes key milestone in digital study
AustraliaAustralian Clinical Labs logs $$35.5M FY26 net profit
AustraliaAustralian Clinical Labs contacts 280,000 individuals
AustraliaGreg Horan appointed CEO of Australian Clinical Labs
AustraliaAustralian Clinical Labs boosts margins despite soft H1 FY26 revenue
Australia
Recent announcements
What Australian Clinical Labs (ACL) has told the market, newest first.
- Ceasing to be a substantial holder
- Correction to Notice of Meeting for 2026 AGM
- Becoming a substantial holder
- Change of Auditor
- Appointment of non-executive director - Dr Amandeep Hansra
- Update on third party cyber incident impacting SunDoctors
Dividend history
Dividends per share paid by Australian Clinical Labs, by financial year.
| Financial year | Interim | Final | Special | Total |
|---|---|---|---|---|
| FY2027(to date) | A$0.0925 | — | — | A$0.0925 |
| FY2026 | A$0.0900 | A$0.0375 | — | A$0.1275 |
| FY2025 | A$0.0900 | A$0.0350 | — | A$0.1250 |
| FY2024 | A$0.0700 | A$0.0300 | — | A$0.1000 |
| FY2023 | A$0.4100 | A$0.0700 | — | A$0.4800 |
Key financials
Reported results for Australian Clinical Labs, in AUD.
- Market cap
- 604.3M
- Revenue (TTM)
- 736.2M
- P/E ratio
- 27.0
- EPS (diluted, TTM)
- 0.1
- Dividend yield
- 4.1%
- Profit margin
- 3.2%
| Fiscal year end | Revenue | Operating income | Net income |
|---|---|---|---|
| 729.5M | 61.5M | 23.7M | |
| 741.3M | 270.9M | 32.4M | |
| 689.7M | 56.9M | 23.9M | |
| 692.1M | 56.1M | 35.9M |